COL5A2 and cancer: In summary, we identified nine hub genes (COL1A1, COL1A2, COL3A1, COL5A1, COL5A2, COL6A3, EMILIN1, MMP2, THY1) as potential participants in implying cancer stemness and immunotherapy resistance.